bevacizumab

bevacizumab

美 　英

• 网络贝伐单抗；贝伐珠单抗；贝伐株单抗

例句

"Our hope now, " he added, "is to see greater improvement by using bevacizumab at earlier stages of the disease. "

他补充说：“我们的希望是看到在疾病早期用贝伐单抗就能显著改善患者病情。”

In the phase II study, the rate of life-threatening and fatal pulmonary hemorrhages had been increased with bevacizumab treatment (9. 1%).

在II期研究中，贝伐单抗治疗导致的致命率和致死性肺出血就已经增加（9.1%）。

Patients taking higher dosages of bevacizumab had the greatest risk of developing proteinuria.

接受更高剂量的贝伐单抗的患者有更大的患蛋白尿的风险。

Bevacizumab treatment was associated with a low rate of serious adverse events.

贝伐单抗治疗严重不良事件率很低。

Bevacizumab, a recombinant humanized anti-VEGF monoclonal antibody, has proven beneficial to cancer therapy.

贝伐单抗为重组人源化抗VEGF的单克隆抗体，其治疗肿瘤具有良好的效果。

ObjectiveTo evaluate the efficacy and safety of bevacizumab plus capecitabine in treating metastatic colorectal cancer(mCRC).

目的观察贝伐单抗联合卡培他滨治疗转移性结直肠癌的疗效及不良反应。

The use of bevacizumab (as well as cetuximab) for maintenance remains unproven, however.

贝伐单抗（以及西妥昔单抗）对维持治疗仍无提高。

This trial provides level-one evidence for the use of bevacizumab injections for the treatment of wet AMD, they conclude.

他们得出结论，这项试验提供了贝伐单抗注射用于治疗湿性老年黄斑变性AMD一级证据。

Avastin, the trade name of bevacizumab, is marketed by Swiss pharmaceutical giant Roche.

阿瓦斯丁是贝伐单抗的商品名，这种药由瑞士罗氏制药企业在市场上出售。

At one point Avastin, also called bevacizumab, seemed a shoo-in to be approved for breast cancer.

从治疗效果来讲，阿瓦斯汀，又被称为贝伐单抗，似乎呼声很高地被批准成为乳腺癌治疗用药。

Bevacizumab is a medication that helps your body fight cancer .

贝伐单抗是一种药，有助于身体对抗癌症。

So if we go back, for example, to the drug bevacizumab in connection with advanced breast cancer. . .

因此，让我们回到抗癌药物上来，例如，晚期乳腺癌的药物-贝伐株单抗。

Adverse reactions to bevacizumab and its combination with chemotherapy regimen

贝伐单抗及其联用化疗方案的不良反应

Assessment of the Efficacy and Safety of Bevacizumab Plus Carboplatin and Paclitaxel in Patients with Non-Small Cell Lung Cancer

贝伐单抗联合卡铂加紫杉醇在非小细胞肺癌中的疗效与安全性评价